4//SEC Filing
Karnani Vikram 4
Accession 0001062993-24-019165
CIK 0001267565other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:50 PM ET
Size
7.5 KB
Accession
0001062993-24-019165
Insider Transaction Report
Form 4
Karnani Vikram
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-11-12+105,972→ 105,972 total - Award
Stock Option (Right to Purchase)
2024-11-12+130,344→ 130,344 totalExercise: $31.41Exp: 2034-11-12→ Common Stock (130,344 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on November 12, 2025, with the balance vesting in three annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Twenty-five percent (25%) of the option shall vest and become exercisable on November 12, 2025, with the balance vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001699488
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:50 PM ET
- Size
- 7.5 KB